How should patients with Barrett's esophagus be monitored?

Michael Grover, Carmen Strickland, Ellen Kesler, Paul Crawford

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Some patients who have been diagnosed with Barrett's esophagus will develop dysplasia and, in some cases, esophageal carcinoma (strength of recommendation [SOR]: A, based on consistent cohort studies). Endoscopic surveillance is recommended for all patients with Barrett's esophagus as it is superior to other methods for detecting esophageal cancer (SOR: B, based on systematic review). The degree of dysplasia noted on biopsy specimens correlates with the risk of esophageal carcinoma development and should guide the frequency of subsequent evaluations (SOR: B, based on consistent cohort studies). The optimal frequency of endoscopy has yet to be determined in any randomized trial. Recommendations from the 2002 American College of Gastroenterology (ACG) Practice Guideline provide guidance as to the frequency of endoscopy surveillance but were not based on an explicit systematic review of the literature (SOR: C, based on expert opinion).

Original languageEnglish
Pages (from-to)243-7
Number of pages5
JournalJournal of Family Practice
Issue number3
StatePublished - Mar 2006


  • Adenocarcinoma/pathology
  • Barrett Esophagus/pathology
  • Biopsy
  • Endoscopy, Digestive System
  • Esophageal Neoplasms/pathology
  • Humans


Dive into the research topics of 'How should patients with Barrett's esophagus be monitored?'. Together they form a unique fingerprint.

Cite this